Despite achieving targets for low-density lipoprotein (LDL) cholesterol, blood pressure, and
glycemia in accordance with current standards of care, patients with dyslipidemia remain at …

Type 1 diabetes (T1D) patients show lipid disorders which are likely to play a role in their
increased cardiovascular (CV) disease risk. Quantitative abnormalities of lipoproteins are …

Oxidative stress is an essential component in the progression of diabetic kidney disease
(DKD), and the transcription factor NF-E2-related factor-2 (Nrf2) plays critical roles in …

Background—Microvascular renal and retinal diseases are common major complications of
type 2 diabetes mellitus. The relation between plasma lipids and microvascular disease is …

Chronic renal disease is accompanied by characteristic abnormalities of lipid metabolism,
which appear as a consequence of nephrotic syndrome or renal insufficiency and are …

Background Chronic kidney disease (CKD) is a long-term condition and has been described
as the gradual loss of kidney function over time. Early in the disease process, people with …

Metabolic syndrome and its components are associated with chronic kidney disease (CKD)
development. Insulin resistance (IR) plays a central role in the metabolic syndrome and is …

Results Mean age of the study population was 58.2 years, and the mean GFR was 44.9
ml/min per 1.73 m 2; 48% of patients had diabetes. None of the lipid or lipoprotein measures …

Abstract Type I (T1) diabetes, also called insulin dependent diabetes mellitus (IDDM), is
characterized by little or no insulin production and hyperglycemia. One of the less well …

Dyslipidemia and the progression of renal disease in chronic renal failure patients
Dyslipidemia is a common complication of progressive kidney disease and contributes to the …